 | • レポートコード：GIR-105X01044 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗エイズ薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗エイズ薬の種類別市場規模（処方薬、非処方薬）、用途別市場規模（薬局、病院）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗エイズ薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GSK、Cipla、MSD、Gilead Sciences、Frontier Biotechnologies ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：処方薬、非処方薬 ・用途別分析2016年-2026年：薬局、病院 ・抗エイズ薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗エイズ薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗エイズ薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗エイズ薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗エイズ薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti-AIDs Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anti-AIDs Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Anti-AIDs Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anti-AIDs Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prescription Drugs
Non-prescription Drugs
Market segment by Application can be divided into
Pharmacy
Hospital
The key market players for global Anti-AIDs Drug market are listed below:
GSK
Cipla
MSD
Gilead Sciences
Frontier Biotechnologies
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anti-AIDs Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-AIDs Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Prescription Drugs
1.2.3 Non-prescription Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-AIDs Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pharmacy
1.3.3 Hospital
1.4 Global Anti-AIDs Drug Market Size & Forecast
1.4.1 Global Anti-AIDs Drug Sales in Value (2016-2026))
1.4.2 Global Anti-AIDs Drug Sales in Volume (2016-2026)
1.4.3 Global Anti-AIDs Drug Price by Type (2016-2026) & (USD/Dose)
1.5 Global Anti-AIDs Drug Production Capacity Analysis
1.5.1 Global Anti-AIDs Drug Total Production Capacity (2016-2026)
1.5.2 Global Anti-AIDs Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-AIDs Drug Market Drivers
1.6.2 Anti-AIDs Drug Market Restraints
1.6.3 Anti-AIDs Drug Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Anti-AIDs Drug Product and Services
2.1.4 GSK Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Cipla
2.2.1 Cipla Details
2.2.2 Cipla Major Business
2.2.3 Cipla Anti-AIDs Drug Product and Services
2.2.4 Cipla Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 MSD
2.3.1 MSD Details
2.3.2 MSD Major Business
2.3.3 MSD Anti-AIDs Drug Product and Services
2.3.4 MSD Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business
2.4.3 Gilead Sciences Anti-AIDs Drug Product and Services
2.4.4 Gilead Sciences Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Frontier Biotechnologies
2.5.1 Frontier Biotechnologies Details
2.5.2 Frontier Biotechnologies Major Business
2.5.3 Frontier Biotechnologies Anti-AIDs Drug Product and Services
2.5.4 Frontier Biotechnologies Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anti-AIDs Drug Sales by Manufacturer
3.1 Global Anti-AIDs Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anti-AIDs Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anti-AIDs Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-AIDs Drug Manufacturer Market Share
3.4.2 Top 6 Anti-AIDs Drug Manufacturer Market Share
3.5 Global Anti-AIDs Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anti-AIDs Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-AIDs Drug Market Size by Region
4.1.1 Global Anti-AIDs Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Anti-AIDs Drug Revenue by Region (2016-2026)
4.2 North America Anti-AIDs Drug Revenue (2016-2026)
4.3 Europe Anti-AIDs Drug Revenue (2016-2026)
4.4 Asia-Pacific Anti-AIDs Drug Revenue (2016-2026)
4.5 South America Anti-AIDs Drug Revenue (2016-2026)
4.6 Middle East and Africa Anti-AIDs Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anti-AIDs Drug Sales in Volume by Type (2016-2026)
5.2 Global Anti-AIDs Drug Revenue by Type (2016-2026)
5.3 Global Anti-AIDs Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anti-AIDs Drug Sales in Volume by Application (2016-2026)
6.2 Global Anti-AIDs Drug Revenue by Application (2016-2026)
6.3 Global Anti-AIDs Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anti-AIDs Drug Sales by Type (2016-2026)
7.2 North America Anti-AIDs Drug Sales by Application (2016-2026)
7.3 North America Anti-AIDs Drug Market Size by Country
7.3.1 North America Anti-AIDs Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Anti-AIDs Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-AIDs Drug Sales by Type (2016-2026)
8.2 Europe Anti-AIDs Drug Sales by Application (2016-2026)
8.3 Europe Anti-AIDs Drug Market Size by Country
8.3.1 Europe Anti-AIDs Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Anti-AIDs Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anti-AIDs Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Anti-AIDs Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Anti-AIDs Drug Market Size by Region
9.3.1 Asia-Pacific Anti-AIDs Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anti-AIDs Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anti-AIDs Drug Sales by Type (2016-2026)
10.2 South America Anti-AIDs Drug Sales by Application (2016-2026)
10.3 South America Anti-AIDs Drug Market Size by Country
10.3.1 South America Anti-AIDs Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Anti-AIDs Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-AIDs Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Anti-AIDs Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Anti-AIDs Drug Market Size by Country
11.3.1 Middle East & Africa Anti-AIDs Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anti-AIDs Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anti-AIDs Drug Typical Distributors
12.3 Anti-AIDs Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anti-AIDs Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anti-AIDs Drug Revenue by Application, (USD Million), 2021-2026
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Anti-AIDs Drug Product and Services
Table 6. GSK Anti-AIDs Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Cipla Basic Information, Manufacturing Base and Competitors
Table 8. Cipla Major Business
Table 9. Cipla Anti-AIDs Drug Product and Services
Table 10. Cipla Anti-AIDs Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. MSD Basic Information, Manufacturing Base and Competitors
Table 12. MSD Major Business
Table 13. MSD Anti-AIDs Drug Product and Services
Table 14. MSD Anti-AIDs Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 16. Gilead Sciences Major Business
Table 17. Gilead Sciences Anti-AIDs Drug Product and Services
Table 18. Gilead Sciences Anti-AIDs Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Frontier Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 20. Frontier Biotechnologies Major Business
Table 21. Frontier Biotechnologies Anti-AIDs Drug Product and Services
Table 22. Frontier Biotechnologies Anti-AIDs Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Anti-AIDs Drug Sales by Manufacturer (2019-2021e) & (K Doses)
Table 24. Global Anti-AIDs Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Anti-AIDs Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Anti-AIDs Drug Production Capacity by Company, (K Doses): 2020 VS 2021
Table 27. Head Office and Anti-AIDs Drug Production Site of Key Manufacturer
Table 28. Global Anti-AIDs Drug Sales by Region (2016-2021e) & (K Doses)
Table 29. Global Anti-AIDs Drug Sales by Region (2021-2026) & (K Doses)
Table 30. Global Anti-AIDs Drug Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Anti-AIDs Drug Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Anti-AIDs Drug Sales by Type (2016-2021e) & (K Doses)
Table 33. Global Anti-AIDs Drug Sales by Type (2021-2026) & (K Doses)
Table 34. Global Anti-AIDs Drug Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Anti-AIDs Drug Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Anti-AIDs Drug Price by Type (2016-2021e) & (USD/Dose)
Table 37. Global Anti-AIDs Drug Price by Type (2021-2026) & (USD/Dose)
Table 38. Global Anti-AIDs Drug Sales by Application (2016-2021e) & (K Doses)
Table 39. Global Anti-AIDs Drug Sales by Application (2021-2026) & (K Doses)
Table 40. Global Anti-AIDs Drug Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Anti-AIDs Drug Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Anti-AIDs Drug Price by Application (2016-2021e) & (USD/Dose)
Table 43. Global Anti-AIDs Drug Price by Application (2021-2026) & (USD/Dose)
Table 44. North America Anti-AIDs Drug Sales by Country (2016-2021e) & (K Doses)
Table 45. North America Anti-AIDs Drug Sales by Country (2021-2026) & (K Doses)
Table 46. North America Anti-AIDs Drug Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Anti-AIDs Drug Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Anti-AIDs Drug Sales by Type (2016-2021e) & (K Doses)
Table 49. North America Anti-AIDs Drug Sales by Type (2021-2026) & (K Doses)
Table 50. North America Anti-AIDs Drug Sales by Application (2016-2021e) & (K Doses)
Table 51. North America Anti-AIDs Drug Sales by Application (2021-2026) & (K Doses)
Table 52. Europe Anti-AIDs Drug Sales by Country (2016-2021e) & (K Doses)
Table 53. Europe Anti-AIDs Drug Sales by Country (2021-2026) & (K Doses)
Table 54. Europe Anti-AIDs Drug Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Anti-AIDs Drug Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Anti-AIDs Drug Sales by Type (2016-2021e) & (K Doses)
Table 57. Europe Anti-AIDs Drug Sales by Type (2021-2026) & (K Doses)
Table 58. Europe Anti-AIDs Drug Sales by Application (2016-2021e) & (K Doses)
Table 59. Europe Anti-AIDs Drug Sales by Application (2021-2026) & (K Doses)
Table 60. Asia-Pacific Anti-AIDs Drug Sales by Region (2016-2021e) & (K Doses)
Table 61. Asia-Pacific Anti-AIDs Drug Sales by Region (2021-2026) & (K Doses)
Table 62. Asia-Pacific Anti-AIDs Drug Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Anti-AIDs Drug Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Anti-AIDs Drug Sales by Type (2016-2021e) & (K Doses)
Table 65. Asia-Pacific Anti-AIDs Drug Sales by Type (2021-2026) & (K Doses)
Table 66. Asia-Pacific Anti-AIDs Drug Sales by Application (2016-2021e) & (K Doses)
Table 67. Asia-Pacific Anti-AIDs Drug Sales by Application (2021-2026) & (K Doses)
Table 68. South America Anti-AIDs Drug Sales by Country (2016-2021e) & (K Doses)
Table 69. South America Anti-AIDs Drug Sales by Country (2021-2026) & (K Doses)
Table 70. South America Anti-AIDs Drug Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Anti-AIDs Drug Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Anti-AIDs Drug Sales by Type (2016-2021e) & (K Doses)
Table 73. South America Anti-AIDs Drug Sales by Type (2021-2026) & (K Doses)
Table 74. South America Anti-AIDs Drug Sales by Application (2016-2021e) & (K Doses)
Table 75. South America Anti-AIDs Drug Sales by Application (2021-2026) & (K Doses)
Table 76. Middle East & Africa Anti-AIDs Drug Sales by Country (2016-2021e) & (K Doses)
Table 77. Middle East & Africa Anti-AIDs Drug Sales by Country (2021-2026) & (K Doses)
Table 78. Middle East & Africa Anti-AIDs Drug Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Anti-AIDs Drug Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Anti-AIDs Drug Sales by Type (2016-2021e) & (K Doses)
Table 81. Middle East & Africa Anti-AIDs Drug Sales by Type (2021-2026) & (K Doses)
Table 82. Middle East & Africa Anti-AIDs Drug Sales by Application (2016-2021e) & (K Doses)
Table 83. Middle East & Africa Anti-AIDs Drug Sales by Application (2021-2026) & (K Doses)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Anti-AIDs Drug Typical Distributors
Table 87. Anti-AIDs Drug Typical Customers
List of Figures
Figure 1. Anti-AIDs Drug Picture
Figure 2. Global Anti-AIDs Drug Sales Market Share by Type in 2020
Figure 3. Prescription Drugs
Figure 4. Non-prescription Drugs
Figure 5. Global Anti-AIDs Drug Sales Market Share by Application in 2020
Figure 6. Pharmacy
Figure 7. Hospital
Figure 8. Global Anti-AIDs Drug Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 9. Global Anti-AIDs Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Anti-AIDs Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Anti-AIDs Drug Sales (2016-2026) & (K Doses)
Figure 30. Global Anti-AIDs Drug Production Capacity (2016-2026) & (K Doses)
Figure 31. Global Anti-AIDs Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Anti-AIDs Drug Market Drivers
Figure 33. Anti-AIDs Drug Market Restraints
Figure 34. Anti-AIDs Drug Market Trends
Figure 35. Global Anti-AIDs Drug Sales Market Share by Manufacturer in 2020
Figure 36. Global Anti-AIDs Drug Revenue Market Share by Manufacturer in 2020
Figure 37. Anti-AIDs Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Anti-AIDs Drug Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Anti-AIDs Drug Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Anti-AIDs Drug Sales Market Share by Region (2016-2026)
Figure 41. Global Anti-AIDs Drug Revenue Market Share by Region (2016-2026)
Figure 42. North America Anti-AIDs Drug Revenue (2016-2026) & (USD Million)
Figure 43. Europe Anti-AIDs Drug Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Anti-AIDs Drug Revenue (2016-2026) & (USD Million)
Figure 45. South America Anti-AIDs Drug Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Anti-AIDs Drug Revenue (2016-2026) & (USD Million)
Figure 47. Global Anti-AIDs Drug Sales Market Share by Type (2016-2026)
Figure 48. Global Anti-AIDs Drug Revenue Market Share by Type (2016-2026)
Figure 49. Global Anti-AIDs Drug Price by Type (2016-2026) & (USD/Dose)
Figure 50. Global Anti-AIDs Drug Sales Market Share by Application (2016-2026)
Figure 51. Global Anti-AIDs Drug Revenue Market Share by Application (2016-2026)
Figure 52. Global Anti-AIDs Drug Price by Application (2016-2026) & (USD/Dose)
Figure 53. North America Anti-AIDs Drug Sales Market Share by Country (2016-2026)
Figure 54. North America Anti-AIDs Drug Revenue Market Share by Country (2016-2026)
Figure 55. North America Anti-AIDs Drug Sales Market Share by Type (2016-2026)
Figure 56. North America Anti-AIDs Drug Sales Market Share by Application (2016-2026)
Figure 57. Europe Anti-AIDs Drug Sales Market Share by Country (2016-2026)
Figure 58. Europe Anti-AIDs Drug Revenue Market Share by Country (2016-2026)
Figure 59. Europe Anti-AIDs Drug Sales Market Share by Type (2016-2026)
Figure 60. Europe Anti-AIDs Drug Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Anti-AIDs Drug Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Anti-AIDs Drug Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Anti-AIDs Drug Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Anti-AIDs Drug Sales Market Share by Application (2016-2026)
Figure 65. South America Anti-AIDs Drug Sales Market Share by Country (2016-2026)
Figure 66. South America Anti-AIDs Drug Revenue Market Share by Country (2016-2026)
Figure 67. South America Anti-AIDs Drug Sales Market Share by Type (2016-2026)
Figure 68. South America Anti-AIDs Drug Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Anti-AIDs Drug Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Anti-AIDs Drug Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Anti-AIDs Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Anti-AIDs Drug Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
結核薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Tuberculosis (TB) is an infectious disease, which is caused by Mycobacterium tuberculosis. These bacteria generally infect human lungs. However, it can infect other body parts/organs as well. Three major types of tuberculosis are found: latent, active, and drug-resistant tuberculosis. Symptoms are n…- 禁煙補助器具の世界市場2018-2025 Smoking cessation Aids, a product that Aids individuals in quitting smoking, essentially replaces smoking, though, without the harmful effects of smoking.Amongst NRT products, NRT Gums has the largest share in the market. Amongst prescription products, inhalers, and sprays have the largest market. I…
- 世界のボックス補聴器市場 2021：企業別、地域別、種類・用途別 The Box Hearing Aids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の減量薬市場 2021：企業別、地域別、種類・用途別 The Slimming Aids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…
- 世界の補聴器3D印刷装置市場 2021：企業別、地域別、種類・用途別 The Hearing Aids 3D Printing Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…